Role of sympathetic nervous system in cyclosporine-induced rise in blood pressure

Hypertension

Volumn 34, Issue 1, 1999, Pages 102-106

  Carvalho, Mario J ^a   Van Den Meiracker, Anton H ^b   Boomsma, Frans ^b   Freitas, Joao ^a   Man In 't Veld, Arie J ^b   Costa, Ovidio ^a   De Freitas, Antonio Falcão ^a  

^a University of Porto   (Portugal)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Amyloid neuropathies; Blood pressure monitoring, ambulatory; Cyclosporine; Transplantation, liver

Indexed keywords

CYCLOSPORIN;

ADRENERGIC SYSTEM; ADULT; AMYLOID NEUROPATHY; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HUMAN; HYPERTENSION; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL;

EID: 0032769318     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.1.102     Document Type: Article

References (28)

1. Saraiva MJM, Costa PP, Goodman DS. Biochemical marker in familial amyloidotic polyneuropathy. Portugese type: family studies on the transthyretin (prealbumin)-methionine 30 variant. J Clin Invest. 1985;76:2171-2177.
2. Andrade CA. A peculiar form of peripheral neuropathy: familial atypical generalized amyloidosis with special involvement of peripheral nerves. Brain. 1952;75:408-427.
3. Carvalho MJ, van den Meiracker AH, Boomsma F, Man in 't Veld AJ, Freitas J, Costa O, Falcao de Freitas A. Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydroxyphenylserine. J Auton Nerv Syst. 1997;62:63-71.
4. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet. 1993;341:1113-1116.
5. Starzl TE, Demeteris AJ, Van Tiel D. Liver transplantation. N Engl J Med. 1989;321:1014-1022.
6. Taler SJ, Textor SC, Ganzanello VJ, Schwartz L, Porayko M, Wiesner RH, Krom RA. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. Transplantation. 1996;62:1588-1592.
7. Textor SC. De novo hypertension after liver transplantation. Hypertension. 1993;22:257-267.
8. Frist WH, Stinson EB, Oyer PE, Baldwin JC, Shumway NE. Long-term hemodynamic results after cardiac transplantation. J Thorac Cardiovasc Surg. 1987;94:685-693.
9. Greenberg ML, Uretsky BF, Reddy PS, Bernstein RL, Griffith BP, Hardesty RL, Thompson ME, Bahnson HT. Long-term hemodynamic follow-up of cardiac transplant patients treated with cyclosporine and prednisone. Circulation. 1985;71:487-494.
10. Scherrer U, Vissing SF, Morgan BJ, Rollins JA, Tindall RSA, Ring S, Hanson P, Mohanty PK, Victor RG. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med. 1990;323:639-699.
11. Kaye D, Thompson J, Jennings G, Esler M. Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation. Circulation. 1993;88:1101-1109.
12. Floras JS, Legault L, Morali GA, Hara K, Blendis LM. Increased sympathetic outflow in cirrhosis and ascites: direct evidence from intraneural recordings. Ann Intern Med. 1991;114:373-380.
13. Stein CM, He H, Pincus Th, Wood AJJ. Cyclosporine impairs vasodilation without increased sympathetic activity in humans. Hypertension. 1995;26:705-710.
14. Lucini D, Milani RV, Ventura HO, Mehra MR, Messerli FH, Murgo JP, Regenstein F, Copley B, Malliani A, Pagani M. Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control. J Heart Lung Transplant. 1997;16:615-620.
15. Ewing DJ, Clarke BF. Autonomic neuropathy: its diagnosis and prognosis. Clin Endocrinol Metab. 1985;15:855-888.
16. nd ed. Oxford, UK: Oxford Medical Publications; 1988:289-307.
17. van den Hoorn FAJ, Boomsma F, Man in 't Veld AJ, Schalekamp MADH. Determination of catecholamines in human plasma by high performance liquid chromatography: comparison between a new method with fluorescence detection and an established method with electrochemical detection. J Chromatogr. 1989;487:17-27.
18. Reeves RA, Shapiro AP, Thompson ME, Johnsen AM. Loss of nocturnal decline in BP after cardiac transplantation. Circulation. 1986;73:401-408.
19. Idema RN, van den Meiracker AH, Balk AHHM, Bos E, Schalekamp MADH, Man in 't Veld AJ. Abnormal diurnal variation of blood pressure, cardiac output and vascular resistance in cardiac transplant patients. Circulation. 1994;90:2797-2803.
20. Van den Dorpel MA, van den Meiracker AH, Lameris TW, Boomsma F, Levi M, Man in 't Veld AJ, Weimar W, Schalekamp MADH. Cyclosporine A impairs the nocturnal blood pressure fall in renal transplant recipients. Hypertension. 1996;28:304-307.
21. N-cholinergic blockade in dissecting the components of cardiovascular regulation. Hypertension. 1998;32:101-107.
22. Sander M, Lyson T, Thomas GD, Victor RG. Sympathetic neural mechanisms of cyclosporine-induced hypertension. Am J Hypertens. 1996;9:121S-138S.
23. Van de Borne P, Leerman M, Primo G, Degaute J-P. Reappearance of a normal circadian rhythm of blood pressure after cardiac transplantation. Am J Cardiol. 1992;69:794-801.
24. Bantle JP, Boudreau RJ, Ferris TF. Suppression of plasma renin activity by cyclosporine. Am J Med. 1987;83:59-64.
25. Ciresi DL, Lloyd MA, Sandberg SM, Heublein DM, Edwards BS. The sodium retaining effect of cyclosporine. Kidney Int. 1992;41:1599-1605.
26. Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology. 1996; 47:944-951.
27. Pomfret EA, Lewis WD, Jenkins RL, Bergethon P, Dubrey SW, Reisinger J, Falk RH, Skinner M. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation. 1998;65:918-925.
28. Richards NT, Poston L, Hilton PJ. Cyclosporine A inhibits endothelium-dependent, prostanoid-induced relaxation in human subcutaneous resistance vessels. J Hypertens. 1990;8:159-163.